CN102488650A - 一种环磷腺苷药物组合物及其制备方法 - Google Patents
一种环磷腺苷药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN102488650A CN102488650A CN2011104247902A CN201110424790A CN102488650A CN 102488650 A CN102488650 A CN 102488650A CN 2011104247902 A CN2011104247902 A CN 2011104247902A CN 201110424790 A CN201110424790 A CN 201110424790A CN 102488650 A CN102488650 A CN 102488650A
- Authority
- CN
- China
- Prior art keywords
- injection
- adenosine cyclophosphate
- sodium hydroxide
- peg400
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 title claims abstract description 65
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 138
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims abstract description 33
- 238000002347 injection Methods 0.000 claims abstract description 33
- 239000007924 injection Substances 0.000 claims abstract description 33
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims abstract description 33
- 230000008901 benefit Effects 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 20
- 239000008215 water for injection Substances 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 14
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 13
- 229930195725 Mannitol Natural products 0.000 claims description 13
- 239000000594 mannitol Substances 0.000 claims description 13
- 235000010355 mannitol Nutrition 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 12
- 238000007689 inspection Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 8
- 238000005262 decarbonization Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000011265 semifinished product Substances 0.000 claims description 6
- 239000008227 sterile water for injection Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims description 3
- 239000003708 ampul Substances 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 230000002262 irrigation Effects 0.000 claims description 3
- 238000003973 irrigation Methods 0.000 claims description 3
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000000890 drug combination Substances 0.000 claims 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 230000007774 longterm Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 230000002107 myocardial effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000002327 cardiovascular agent Substances 0.000 description 2
- 229940125692 cardiovascular agent Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000008137 solubility enhancer Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110424790 CN102488650B (zh) | 2011-12-19 | 2011-12-19 | 一种环磷腺苷药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110424790 CN102488650B (zh) | 2011-12-19 | 2011-12-19 | 一种环磷腺苷药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102488650A true CN102488650A (zh) | 2012-06-13 |
CN102488650B CN102488650B (zh) | 2013-07-17 |
Family
ID=46180558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110424790 Expired - Fee Related CN102488650B (zh) | 2011-12-19 | 2011-12-19 | 一种环磷腺苷药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102488650B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796156A (zh) * | 2012-08-24 | 2012-11-28 | 宁辉 | 环磷腺苷二葡甲胺化合物及其制备方法 |
CN102846557A (zh) * | 2012-09-20 | 2013-01-02 | 浙江亚太药业股份有限公司 | 一种环磷腺苷冻干制剂及其制备方法 |
CN102988402A (zh) * | 2012-11-29 | 2013-03-27 | 罗诚 | 一种含有环磷腺苷化合物药物组合物及其制备方法 |
CN103006552A (zh) * | 2012-12-18 | 2013-04-03 | 河南辅仁怀庆堂制药有限公司 | 注射用环磷腺苷配制工艺 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1833656A (zh) * | 2005-03-14 | 2006-09-20 | 王玫 | 环磷腺苷注射液及其制备方法 |
CN1923180A (zh) * | 2006-09-22 | 2007-03-07 | 江苏万邦生化医药股份有限公司 | 注射用环磷腺苷葡胺的制备工艺 |
CN101455631A (zh) * | 2009-01-06 | 2009-06-17 | 湖北德康药业有限公司 | 环磷腺苷葡胺注射液及其制备工艺 |
CN101745117A (zh) * | 2008-12-04 | 2010-06-23 | 北京四环制药有限公司 | 环磷腺苷与聚乙烯吡咯烷酮的组合物及其制备方法 |
CN102258531A (zh) * | 2011-04-12 | 2011-11-30 | 宁辉 | 一种含有环磷腺苷与葡甲胺的药物组合物及其制备方法 |
-
2011
- 2011-12-19 CN CN 201110424790 patent/CN102488650B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1833656A (zh) * | 2005-03-14 | 2006-09-20 | 王玫 | 环磷腺苷注射液及其制备方法 |
CN1923180A (zh) * | 2006-09-22 | 2007-03-07 | 江苏万邦生化医药股份有限公司 | 注射用环磷腺苷葡胺的制备工艺 |
CN101745117A (zh) * | 2008-12-04 | 2010-06-23 | 北京四环制药有限公司 | 环磷腺苷与聚乙烯吡咯烷酮的组合物及其制备方法 |
CN101455631A (zh) * | 2009-01-06 | 2009-06-17 | 湖北德康药业有限公司 | 环磷腺苷葡胺注射液及其制备工艺 |
CN102258531A (zh) * | 2011-04-12 | 2011-11-30 | 宁辉 | 一种含有环磷腺苷与葡甲胺的药物组合物及其制备方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796156A (zh) * | 2012-08-24 | 2012-11-28 | 宁辉 | 环磷腺苷二葡甲胺化合物及其制备方法 |
CN102796156B (zh) * | 2012-08-24 | 2014-07-30 | 宁辉 | 环磷腺苷二葡甲胺化合物及其制备方法 |
CN102846557A (zh) * | 2012-09-20 | 2013-01-02 | 浙江亚太药业股份有限公司 | 一种环磷腺苷冻干制剂及其制备方法 |
CN102988402A (zh) * | 2012-11-29 | 2013-03-27 | 罗诚 | 一种含有环磷腺苷化合物药物组合物及其制备方法 |
CN103006552A (zh) * | 2012-12-18 | 2013-04-03 | 河南辅仁怀庆堂制药有限公司 | 注射用环磷腺苷配制工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN102488650B (zh) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101502494B (zh) | 一种盐酸溴己新冻干粉针剂及其制备方法 | |
CN102488650B (zh) | 一种环磷腺苷药物组合物及其制备方法 | |
CN102258531B (zh) | 一种含有环磷腺苷与葡甲胺的药物组合物及其制备方法 | |
EP2750664A1 (en) | Levothyroxine formulations | |
CN101791310B (zh) | 长春西汀药物组合物及其制备方法 | |
AU2018204334A1 (en) | Improved daptomycin injectable formulation | |
CN102525963B (zh) | 一种硫酸奈替米星冻干粉针及其制备方法 | |
CN102525930A (zh) | 一种硫辛酸脂质体注射剂 | |
CN103040910A (zh) | 一种鹿瓜多肽脂质体注射剂 | |
US9393230B2 (en) | Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumor activity, and method for producing said composition (alternatives) | |
KR20230131815A (ko) | 에토포시드 토니리베이트 제제 | |
JP6063064B2 (ja) | 安定したノカチアシン凍結乾燥製剤 | |
CN100525758C (zh) | 藤黄酸脂质体及其冻干粉针剂与制备方法 | |
CN102342931A (zh) | 替莫唑胺的可注射的胃肠外用药物制剂及其制备方法 | |
CN104688676A (zh) | 穿心莲内酯浓缩型液体组方及其医药用途 | |
CN104473873B (zh) | 一种卡巴他赛长循环脂质体注射剂及其制备方法 | |
CN103877032B (zh) | 一种注射用维库溴铵药物组合物及其制备方法 | |
CN102106846A (zh) | 左旋盐酸艾司洛尔药物组合物及其制备方法 | |
CN103520186B (zh) | 一种注射用脂溶性维生素的药物组合物及其制备方法 | |
CN107693496A (zh) | 一种注射用地加瑞克冻干粉针及制备工艺 | |
CN103735522B (zh) | 一种炎琥宁冻干粉针及其制备方法 | |
CN102327239A (zh) | 鲑鱼降钙素纳米脂质体注射剂及制备方法 | |
CN108289897B (zh) | 一种瑞马唑仑的药物组合物 | |
CN107362144B (zh) | 一种鲁拉西酮脑靶向脂质体注射剂及其制备方法 | |
US20190070123A1 (en) | Transdermal preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120613 Assignee: Guangdong encyclopedia Pharmaceutical Co.,Ltd. Assignor: Wang Baoming Contract record no.: 2013990000463 Denomination of invention: Adenosine cyclophosphate pharmaceutical composition and preparation method thereof Granted publication date: 20130717 License type: Common License Record date: 20130802 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120613 Assignee: Qingdao Jinfeng Pharmaceutical Co., Ltd. Assignor: Wang Baoming Contract record no.: 2014990000099 Denomination of invention: Adenosine cyclophosphate pharmaceutical composition and preparation method thereof Granted publication date: 20130717 License type: Common License Record date: 20140303 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160121 Address after: 100022 Beijing Jianguo Road No. 93, building 12, building 1901, No. Patentee after: Beijing Bobangjiayuan Medical Technology Development Co.,Ltd. Address before: Room 12, building 93, Wanda Plaza, No. 100022 Jianguo Road, Beijing, Chaoyang District, China Patentee before: Wang Baoming |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161222 Address after: 100022 Beijing Jianguo Road No. 93, building 12, building 1901, No. Patentee after: XIZANG JIURUI HEALTH Co.,Ltd. Address before: 100022 Beijing Jianguo Road No. 93, building 12, building 1901, No. Patentee before: Beijing Bobangjiayuan Medical Technology Development Co.,Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: XIZANG JIURUI HEALTH Co.,Ltd. Document name: Notification of Passing Examination on Formalities |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100022 Beijing Jianguo Road No. 93, building 12, building 1901, No. Patentee after: JIURUI health Co.,Ltd. Address before: 100022 Beijing Jianguo Road No. 93, building 12, building 1901, No. Patentee before: XIZANG JIURUI HEALTH Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130717 Termination date: 20201219 |